Aware Super Pty LTD As Trustee Of Aware Super Alnylam Pharmaceuticals, Inc. Transaction History
Aware Super Pty LTD As Trustee Of Aware Super
- $6.27 Trillion
- Q4 2024
A detailed history of Aware Super Pty LTD As Trustee Of Aware Super transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Aware Super Pty LTD As Trustee Of Aware Super holds 13,665 shares of ALNY stock, worth $3.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,665Holding current value
$3.5 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
673Shares Held
112MCall Options Held
943KPut Options Held
922K-
Capital World Investors Los Angeles, CA16.6MShares$4.26 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.27 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.45 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.79 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.12 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...